Lifebit Appoints General Manager to Spearhead Global Expansion
LONDON, UK - Sep 8, 2020 - Lifebit Biotech announced today the appointment of Frank Seo, who joins the company as General Manager. Responsible for the development and implementation of Lifebits growth strategy and overall management of commercial operations, Frank will spearhead global customer success, partnerships and growth across the Lifebit solution suite.
A recognised authority in life sciences software best practices, Frank has served as the leading expert for some of the highest priority digital projects for the top 50 pharmaceutical organisations. He held key advisory roles in the European Biotech and Biopharmaceutical markets for Veeva Systems Inc., the leader in cloud-based software for the global life sciences industry. In leadership positions that included Vice President - Enterprise Strategy, Vice President EU Commercial Strategy, Vice President of Business Development, and General Manager - South Korea, Frank launched Veeva into new international markets, directed flagship product launches, and architected multi-channel strategies that drove unprecedented growth.
We are absolutely thrilled to welcome Frank Seo, said Dr Maria Chatzou Dunford, Lifebit CEO. Frank played a key role in building Veeva into the powerhouse industry leader it is today - that experience will underpin his success as he takes the helm as General Manager to guide our rapidly growing markets globally. Frank is a true visionary and an inspirational pioneer, the perfect balance of energy and extreme delivery that defines Lifebit. It is rare to find an individual who embodies such a broad skill set and depth of experience in life sciences.
Widely respected across the global pharmaceutical and biotechnology industries, Frank is a specialist in regional strategies and multi-country business architectures. His distinguished leadership in life sciences makes him a clear choice for this vital role. Working alongside CEO Dr Maria Chatzou Dunford and CTO Dr Pablo Prieto Barja, Franks leadership is a tremendous asset as Lifebit rapidly scales its international operations.
Sandy McKinnon of Pentech Ventures, Lifebit investor and board member, said, Frank is the ideal executive to lead Lifebit through the next phases of innovation and growth. Having built top tier senior leadership teams from the ground up across multiple countries and geographic regions, Franks deep life sciences knowledge and operational expertise will supercharge our mission as we continue to revolutionise genomics and bioinformatics globally.
Lifebit is driving the new genomics revolution in drug discovery and precision medicine, said Frank Seo. With the worlds first end-to-end Genomic Analysis and Biomarker Discovery Suite, Lifebit has cracked the code. I am excited and eager to get this game changing technology into the hands of all the leading life sciences organisations to help put more medicine and life-saving treatments into the world. By joining this talented team and sharing in the Lifebit mission I have the unique opportunity to help write the next chapter in innovation for our partners and customers around the world.
Frank is a key opinion leader and speaker on global best practices within the life sciences information technology sector.
Media can access Frank Seo's photo here:
https://drive.google.com/file/d/1MAxXwoA_PwG7fSefe_A3XlDFIAP8yFs6/view?usp=sharing
ABOUT LIFEBIT
Lifebit is democratising our understanding of genomics and medical big data to leap forward cures and enhance life. Its federated cloud operating system, Lifebit CloudOS, delivers powerful analysis, computation and data management where big data resides, putting an end to unnecessary and risky data movements. Truly end-to-end, it takes raw data all the way through insights, accelerating genomics research and speeding time to enriched insights in personalised medicine and drug-discovery. Researchers can quickly combine, browse and analyse data, seamlessly collaborate, and drastically reduce time and costs, all while harnessing the power of federation and AI.